AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 69 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $58,000 | +41.5% | 103,275 | 0.0% | 0.00% | – |
Q4 2018 | $41,000 | -60.6% | 103,275 | -50.0% | 0.00% | – |
Q3 2018 | $104,000 | -54.2% | 206,550 | +100.0% | 0.00% | – |
Q2 2018 | $227,000 | +194.8% | 103,275 | +7.9% | 0.00% | – |
Q1 2017 | $77,000 | -10.5% | 95,688 | 0.0% | 0.00% | – |
Q4 2016 | $86,000 | +62.3% | 95,688 | +34.0% | 0.00% | – |
Q3 2016 | $53,000 | -42.4% | 71,416 | 0.0% | 0.00% | – |
Q2 2016 | $92,000 | -78.1% | 71,416 | +27.8% | 0.00% | -100.0% |
Q1 2015 | $421,000 | +119.3% | 55,895 | 0.0% | 0.00% | – |
Q4 2014 | $192,000 | -2.5% | 55,895 | 0.0% | 0.00% | – |
Q3 2014 | $197,000 | -57.8% | 55,895 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $467,000 | +65.6% | 55,895 | +25.7% | 0.00% | 0.0% |
Q1 2014 | $282,000 | -11.0% | 44,457 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $317,000 | +9.7% | 44,457 | +15.6% | 0.00% | 0.0% |
Q3 2013 | $289,000 | +30.2% | 38,467 | -0.0% | 0.00% | 0.0% |
Q2 2013 | $222,000 | – | 38,469 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cypress Capital Management LLC (WY) | 234,225 | $132,000 | 0.18% |
Noven Financial Group, Inc. | 123,772 | $70,000 | 0.04% |
Harvest Investment Services, LLC | 109,443 | $60,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 559,489 | $314,000 | 0.03% |
COURIER CAPITAL LLC | 354,973 | $199,000 | 0.03% |
Valeo Financial Advisors, LLC | 330,000 | $185,000 | 0.02% |
Transform Wealth, LLC | 205,481 | $115,000 | 0.02% |
WEDBUSH SECURITIES INC | 326,793 | $184,000 | 0.02% |
STEEL GROVE CAPITAL ADVISORS, LLC | 55,500 | $31,000 | 0.02% |
MONTAG A & ASSOCIATES INC | 230,000 | $129,000 | 0.01% |